<DOC>
	<DOCNO>NCT00133679</DOCNO>
	<brief_summary>The purpose study test sildenafil effective treatment infant severe congenital diaphragmatic hernia ( determine presence prolong pulmonary hypertension prolong oxygen supplementation mechanical ventilation ) , measure estimate pulmonary artery systolic pressure follow treatment .</brief_summary>
	<brief_title>Chronic Sildenafil Severe Diaphragmatic Hernia</brief_title>
	<detailed_description>Congenital diaphragmatic hernia ( CDH ) condition characterize pulmonary parenchymal vascular hypoplasia . Severe CDH carry high rate mortality , significant morbidity among survivor . This proposal randomize , blind , placebo-controlled study design evaluate efficacy potential mechanism activity sildenafil , phosphodiesterase-5 inhibitor , treatment severe CDH . Infants meet criterion â‰¥10d age predict poor outcome [ death chronic lung disease ( CLD ) severe enough require hospital discharge supplemental oxygen ( O2 ) ] eligible study . Infants whose parent consent study undergo initial echocardiogram ass degree pulmonary hypertension . They begin either sildenafil placebo therapy 45d course . A final echocardiogram perform experimental drug course complete . The pulmonary arterial systolic pressure estimate hyperoxic condition compare sildenafil placebo group . Infants either group severely elevate pulmonary arterial pressure ( despite supplemental O2 ) consider open-label sildenafil , continue hospital discharge , depend result cardiac catheterization perform clinical care .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Hernia , Diaphragmatic</mesh_term>
	<mesh_term>Hernias , Diaphragmatic , Congenital</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Congenital diaphragmatic hernia 1042 day ( ) age Significant illness severity demonstrate : Receiving assist ventilation FiO2 &gt; = 0.40 1014d age , FiO2 &gt; = 0.40 &gt; =48hours 1527d age , FiO2 &gt; = 0.35 2842d age Or , need extracorporeal support &gt; =10d age Or , estimate pulmonary arterial right ventricular systolic pressure &gt; = 2/3 systemic pressure 1442d age Structural congenital heart disease ( patent ductus arteriosus patent foramen ovale/atrial septal defect [ ASD ] nonhemodynamically significant ventricular septal defect [ VSD ] ) Sildenafil contraindicate ( condition resolve ) : Unable absorb oral medication , Unstable systemic blood pressure , Receiving drug may interfere sildenafil metabolism , Renal insufficiency Hepatic insufficiency Previous use sildenafil</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>42 Days</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Chronic lung disease</keyword>
	<keyword>Nitric oxide</keyword>
	<keyword>cyclic guanosine monophosphate</keyword>
	<keyword>phosphodiesterase inhibitor</keyword>
</DOC>